Comparing Logiq (OTCMKTS:LGIQ) & PetMed Express (NASDAQ:PETS)

PetMed Express (NASDAQ:PETS) and Logiq (OTCMKTS:LGIQ) are both retail/wholesale companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Valuation and Earnings

This table compares PetMed Express and Logiq”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetMed Express	$226.97 million	0.21	-$6.27 million	($3.12)	-0.73
Logiq	N/A	N/A	-$20.10 million	N/A	N/A

PetMed Express has higher revenue and earnings than Logiq.

Institutional and Insider Ownership

73.3% of PetMed Express shares are owned by institutional investors. 2.0% of PetMed Express shares are owned by company insiders. Comparatively, 44.7% of Logiq shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for PetMed Express and Logiq, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetMed Express	1	1	0	0	1.50
Logiq	0	0	0	0	0.00

Given Logiq’s higher possible upside, analysts clearly believe Logiq is more favorable than PetMed Express.

Risk & Volatility

PetMed Express has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Comparatively, Logiq has a beta of -1.32, suggesting that its stock price is 232% less volatile than the S&P 500.

Profitability

This table compares PetMed Express and Logiq’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PetMed Express	-35.51%	-70.81%	-33.67%
Logiq	N/A	N/A	N/A

About PetMed Express

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

About Logiq

Logiq, Inc. provides e-commerce solutions and services in the European Union, Southeast Asia, Africa, South Korea, and North America. The company operates its DATALogiq-branded consumer data management platform by lead generation, online marketing, and multichannel reengagement strategies through its owned and operated brands. Its DATALogiq develops a proprietary data management platform and integrates with various third-party service providers to optimize the return on its marketing efforts. The company was formerly known as Weyland Tech Inc. and changed its name to Logiq, Inc. in September 2020. Logiq, Inc. was incorporated in 2004 and is headquartered in New York, New York.